These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 28280494)

  • 1. A Chimera Containing CD4+ and CD8+ T-Cell Epitopes of the
    Alves-Silva MV; Nico D; Morrot A; Palatnik M; Palatnik-de-Sousa CB
    Front Immunol; 2017; 8():100. PubMed ID: 28280494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The F1F3 Recombinant Chimera of
    Alves-Silva MV; Nico D; de Luca PM; Palatnik de-Sousa CB
    Front Immunol; 2019; 10():724. PubMed ID: 31024556
    [No Abstract]   [Full Text] [Related]  

  • 3. Cross-Protective Immunity to Leishmania amazonensis is Mediated by CD4+ and CD8+ Epitopes of Leishmania donovani Nucleoside Hydrolase Terminal Domains.
    Nico D; Gomes DC; Alves-Silva MV; Freitas EO; Morrot A; Bahia D; Palatnik M; Rodrigues MM; Palatnik-de-Sousa CB
    Front Immunol; 2014; 5():189. PubMed ID: 24822054
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Barbosa Santos ML; Nico D; de Oliveira FA; Barreto AS; Palatnik-de-Sousa I; Carrillo E; Moreno J; de Luca PM; Morrot A; Rosa DS; Palatnik M; Bani-Corrêa C; de Almeida RP; Palatnik-de-Sousa CB
    Front Immunol; 2017; 8():227. PubMed ID: 28321221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leishmania donovani Nucleoside Hydrolase Terminal Domains in Cross-Protective Immunotherapy Against Leishmania amazonensis Murine Infection.
    Nico D; Gomes DC; Palatnik-de-Sousa I; Morrot A; Palatnik M; Palatnik-de-Sousa CB
    Front Immunol; 2014; 5():273. PubMed ID: 24966857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleoside Hydrolase NH 36: A Vital Enzyme for the
    Palatnik-de-Sousa CB
    Front Immunol; 2019; 10():813. PubMed ID: 31040850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adaptive immunity against Leishmania nucleoside hydrolase maps its c-terminal domain as the target of the CD4+ T cell-driven protective response.
    Nico D; Claser C; Borja-Cabrera GP; Travassos LR; Palatnik M; Soares IS; Rodrigues MM; Palatnik-de-Sousa CB
    PLoS Negl Trop Dis; 2010 Nov; 4(11):e866. PubMed ID: 21085470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NH36 and F3 Antigen-Primed Dendritic Cells Show Preserved Migrating Capabilities and CCR7 Expression and F3 Is Effective in Immunotherapy of Visceral Leishmaniasis.
    Nico D; Martins Almeida F; Maria Motta J; Soares Dos Santos Cardoso F; Freire-de-Lima CG; Freire-de-Lima L; de Luca PM; Maria Blanco Martinez A; Morrot A; Palatnik-de-Sousa CB
    Front Immunol; 2018; 9():967. PubMed ID: 29867949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. F1 Domain of the
    Carrillo E; Fernandez L; Ibarra-Meneses AV; Santos MLB; Nico D; de Luca PM; Correa CB; de Almeida RP; Moreno J; Palatnik-de-Sousa CB
    Front Immunol; 2017; 8():750. PubMed ID: 28747911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-protective efficacy of a prophylactic Leishmania donovani DNA vaccine against visceral and cutaneous murine leishmaniasis.
    Aguilar-Be I; da Silva Zardo R; Paraguai de Souza E; Borja-Cabrera GP; Rosado-Vallado M; Mut-Martin M; García-Miss Mdel R; Palatnik de Sousa CB; Dumonteil E
    Infect Immun; 2005 Feb; 73(2):812-9. PubMed ID: 15664920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination with a CD4
    Dias DS; Ribeiro PAF; Martins VT; Lage DP; Costa LE; Chávez-Fumagalli MA; Ramos FF; Santos TTO; Ludolf F; Oliveira JS; Mendes TAO; Silva ES; Galdino AS; Duarte MC; Roatt BM; Menezes-Souza D; Teixeira AL; Coelho EAF
    Transl Res; 2018 Oct; 200():18-34. PubMed ID: 29908151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleoside hydrolase DNA vaccine against canine visceral leishmaniasis.
    Borja-Cabrera GP; Santos FB; Picillo E; Gravino AE; Manna L; Palatnik-de-Sousa CB
    Procedia Vaccinol; 2009; 1(1):104-109. PubMed ID: 32288909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of multi-epitope peptides containing HLA class-I and class-II-restricted epitopes derived from immunogenic Leishmania proteins, and evaluation of CD4+ and CD8+ T cell responses induced in cured cutaneous leishmaniasis subjects.
    Hamrouni S; Bras-Gonçalves R; Kidar A; Aoun K; Chamakh-Ayari R; Petitdidier E; Messaoudi Y; Pagniez J; Lemesre JL; Meddeb-Garnaoui A
    PLoS Negl Trop Dis; 2020 Mar; 14(3):e0008093. PubMed ID: 32176691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of rapid in vitro co-culture system of macrophages and T-cell subsets to assess the immunogenicity of dogs vaccinated with live attenuated Leishmania donovani centrin deleted parasites (LdCen-/-).
    Viana KF; Fiuza JA; Gannavaram S; Dey R; Selvapandiyan A; Bartholomeu DC; da Silveira-Lemos D; Bueno LL; Dutra WO; Fujiwara RT; Nakhasi HL; Giunchetti RC
    Parasit Vectors; 2016 Apr; 9():250. PubMed ID: 27136900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A recombinant fusion protein displaying murine and human MHC class I- and II-specific epitopes protects against Leishmania amazonensis infection.
    Martins VT; Lage DP; Duarte MC; Carvalho AM; Costa LE; Mendes TA; Vale DL; Menezes-Souza D; Roatt BM; Tavares CA; Soto M; Coelho EA
    Cell Immunol; 2017 Mar; 313():32-42. PubMed ID: 28049560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifunctional, TNF-α and IFN-γ-Secreting CD4 and CD8 T Cells and CD8
    Rodrigues LS; Barreto AS; Bomfim LGS; Gomes MC; Ferreira NLC; da Cruz GS; Magalhães LS; de Jesus AR; Palatnik-de-Sousa CB; Corrêa CB; de Almeida RP
    Front Immunol; 2021; 12():773983. PubMed ID: 34777391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of immune responses and protection induced by A2 and nucleoside hydrolase (NH) DNA vaccines against Leishmania chagasi and Leishmania amazonensis experimental infections.
    Zanin FH; Coelho EA; Tavares CA; Marques-da-Silva EA; Silva Costa MM; Rezende SA; Gazzinelli RT; Fernandes AP
    Microbes Infect; 2007 Jul; 9(9):1070-7. PubMed ID: 17644455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination using live attenuated Leishmania donovani centrin deleted parasites induces protection in dogs against Leishmania infantum.
    Fiuza JA; Gannavaram S; Santiago Hda C; Selvapandiyan A; Souza DM; Passos LS; de Mendonça LZ; Lemos-Giunchetti Dda S; Ricci ND; Bartholomeu DC; Giunchetti RC; Bueno LL; Correa-Oliveira R; Nakhasi HL; Fujiwara RT
    Vaccine; 2015 Jan; 33(2):280-8. PubMed ID: 25475955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perforin and gamma interferon are critical CD8+ T-cell-mediated responses in vaccine-induced immunity against Leishmania amazonensis infection.
    Colmenares M; Kima PE; Samoff E; Soong L; McMahon-Pratt D
    Infect Immun; 2003 Jun; 71(6):3172-82. PubMed ID: 12761096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterologous priming-boosting with DNA and vaccinia virus expressing kinetoplastid membrane protein-11 induces potent cellular immune response and confers protection against infection with antimony resistant and sensitive strains of Leishmania (Leishmania) donovani.
    Guha R; Das S; Ghosh J; Naskar K; Mandala A; Sundar S; Dujardin JC; Roy S
    Vaccine; 2013 Apr; 31(15):1905-15. PubMed ID: 23499564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.